Search Results for keywords:"Siegfried USA, LLC"

Found 4 results
Skip to main content

Search Results: keywords:"Siegfried USA, LLC"

  • Type:Notice
    Citation:86 FR 2458
    Reading Time:less than a minute

    Siegfried USA, LLC has applied to the Drug Enforcement Administration (DEA) to become a registered manufacturer of certain controlled substances in bulk. This application was submitted on December 9, 2020. Interested parties can submit comments, objections, or requests for a hearing regarding this application by March 15, 2021. The purpose of this registration is for Siegfried USA, LLC to produce these substances for sale to their customers, and no other activities with these drugs are permitted under this registration.

    Simple Explanation

    Siegfried USA, LLC asked the government for permission to make certain special medicines in big batches, and people can tell the government if they think it's a good or bad idea.

  • Type:Notice
    Citation:89 FR 106584
    Reading Time:about a minute or two

    Siegfried USA, LLC has submitted an application to the Drug Enforcement Administration (DEA) seeking approval to become an importer of certain controlled substances. The application is intended to allow the company to import these substances for the purpose of manufacturing bulk Active Pharmaceutical Ingredients for its customers. Interested parties, such as registered bulk manufacturers of these controlled substances, are invited to submit comments or objections to this application by January 29, 2025. Comments should be submitted electronically via the Federal eRulemaking Portal, and requests for a hearing can be sent to the DEA at the addresses provided in the document.

    Simple Explanation

    Imagine a company wants to bring special, controlled medicine ingredients into the country so they can help make important medicines. People and other companies can say what they think about this idea until the end of January next year by sending comments online.

  • Type:Notice
    Citation:90 FR 7173
    Reading Time:about a minute or two

    The Drug Enforcement Administration (DEA) has announced that Siegfried USA, LLC, located in Pennsville, New Jersey, has applied to be registered as a bulk manufacturer of certain controlled substances. Interested parties, including registered manufacturers of these substances, can submit comments or objections electronically by March 24, 2025. They can also request a hearing on the application by the same date. This registration will allow Siegfried USA to produce these substances in bulk for sale.

    Simple Explanation

    Siegfried USA, a company in New Jersey, wants permission to make special medicine ingredients in large amounts, and people can tell the government what they think about this by March 24, 2025.

  • Type:Notice
    Citation:86 FR 9540
    Reading Time:about a minute or two

    Siegfried USA, LLC, located in New Jersey, has submitted an application to become an importer of specific controlled substances, as noted by the Drug Enforcement Administration (DEA). The company plans to import these substances to create active pharmaceutical ingredients for its clients, specifically using Phenylacetone to produce Amphetamine. Comments or objections regarding this application are invited by March 18, 2021, and requests for a hearing can also be made by this date. Final permit approval will align with conditions outlined under the relevant U.S. Code and does not permit the commercial import of drug forms approved or non-approved by the Food and Drug Administration (FDA).

    Simple Explanation

    Siegfried USA, LLC wants permission from the government to bring special ingredients into the country to make medicine for their customers. People can say if they think it's a good or bad idea by a certain date, but it's important that these ingredients are used safely and not for anything bad.